|Slideshows|July 1, 2016

Psychiatry Roundup: Orlando, Physicians Unite, Defunct Study

In the aftermath of the Orlando massacre, nearly half a million physicians declared war on gun violence. This story and more in our psychiatry roundup.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

ByJames Rachal, MD

May 16th 2026

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

ByFrank A. Clark, MD,Lindsay Hill, DNP, PMHNP

May 1st 2026

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

ByRonald W. Pies, MD,Cynthia M.A. Geppert, MD, PhD, MA, MPH, MSBE, DPS, MSJ,Mark S. Komrad, MD, DFAPA

April 3rd 2026

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

ByYasuhiro Kotera, PhD

March 25th 2026

Diagnostic Validators and the Question of What Really Exists

ByS. Nassir Ghaemi, MD, MPH,Mark L. Ruffalo, MSW, DPsa

March 23rd 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Psychiatry Roundup: Orlando, Physicians Unite, Defunct Study

Related Content

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

Diagnostic Validators and the Question of What Really Exists

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

Psychiatric Pharmacogenomics: An Overview

Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint

Empowering Patients and Expanding Formulation Options in Schizophrenia Care